Skip to main content

Table 2 Significant changes between control and ED-treated samples after disturbing G1R DMR establishment

From: Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming

       

% MAT allele

 

Organ

ED

Difference (%)

SD (%)

Student’s t -test P value

Imprinted base line

Oil

Treatment

G2 soma trough paternal germ line - DMR DNA methylation (Figure 3 C)

Peg1-Mest

Head

VZ

-9.1

2.523

0.038

YES (MAT)

95

86

Nespas

Embryo

VZ

-6.9

3.150

0.022

YES (MAT)

91

84

Slc38a4 (b)

Lung

VZ

-5.9

1.747

0.006

YES (MAT)

94

88

IG-DMR

Lung

VZ

5.1

1.513

0.010

YES (PAT)

5

10

G2 soma through maternal germ line - DMR DNA methylation (Figure 3 D)

Peg10

Placenta

VZ

-23.4

3.247

0.000

YES (MAT)

100

77

Peg10

Head

VZ

-9.5

2.146

0.035

YES (MAT)

95

85

Nespas (a)

Yolk sac

VZ

-8.5

4.049

0.023

YES (MAT)

80

71

Snrpn

Placenta

VZ

-8.4

4.675

0.049

YES (MAT)

95

86

Snrpn

Head

VZ

-7.7

2.521

0.020

YES (MAT)

94

86

Zac1 (a)

Yolk sac

DEHP

-7.3

2.129

0.037

YES (MAT)

83

76

KvDMR1

Head

BPA

-7.2

1.497

0.001

YES (MAT)

100

93

Peg3

Head

VZ

-6.4

2.483

0.034

YES (MAT)

99

92

Zac1 (a)

Placenta

VZ

-5.9

3.248

0.036

NO

73

67

Zac1 (b)

Placenta

VZ

-5.7

2.239

0.018

NO

66

61

Peg3

Yolk sac

VZ

-5.6

2.541

0.022

YES (MAT)

88

83

Zac1 (a)

Head

VZ

-5.5

1.528

0.036

YES (MAT)

85

79

Rasgrf1

Head

VZ

5.4

1.343

0.003

YES (PAT)

6

12

Rasgrf1

Head

DEHP

5.5

2.038

0.011

YES (PAT)

6

12

Rasgrf1

Heart

DEHP

6.4

1.413

0.003

YES (PAT)

15

22

IG-DMR (a)

Liver

VZ

9.0

1.087

0.002

YES (PAT)

9

18

IG-DMR (a)

Head

VZ

11.2

3.210

0.048

YES (PAT)

4

15

G2 soma through paternal germ line - RNA transcripts (Figure 4 )

Nesp

Lung

DEHP

-14.3

2.166

0.001

NO

45

31

Nesp

Heart

DEHP

-11.9

3.157

0.042

NO

45

33

Slc22a3

Head

VZ

-7.8

2.097

0.027

NO

53

46

Ascl2

Liver

VZ

-7.1

3.323

0.043

NO

77

70

Cdkn1c

Embryo

BPA

-6.7

2.865

0.036

YES (MAT)

99

92

Slc22a3

Liver

VZ

-6.0

2.261

0.011

NO

57

51

Slc22a3

Liver

BPA

-6.0

2.925

0.025

NO

57

51

Cdkn1c

Embryo

VZ

-5.8

1.367

0.021

YES (MAT)

99

93

Cdkn1c

Embryo

DEHP

-5.8

0.535

0.014

YES (MAT)

99

93

Slc22a3

Lung

BPA

-5.7

2.710

0.031

NO

64

58

Usp29

Lung

BPA

5.7

1.424

0.040

YES (PAT)

3

9

Gnasxl

Heart

VZ

6.3

1.940

0.027

NO

26

32

Rasgrf1

Heart

VZ

9.0

0.722

0.006

YES (PAT)

18

27

Gnasxl

Lung

VZ

15.3

3.644

0.002

NO

31

46

G2 soma through maternal germ line - RNA transcripts ( Additional file 3 )

Nesp

Placenta

DEHP

-12.7

4.922

0.034

YES (MAT)

80

67

Slc22a3

Yolk sac

DEHP

-11.0

0.620

0.030

YES (MAT)

97

86

Ascl2

Liver

VZ

-9.4

1.324

0.034

NO

71

61

Gnasxl

Yolk sac

DEHP

-8.6

3.204

0.035

NO

52

43

G3 soma through paternal germ line (lung and heart) - RNA transcripts (Figure 5 B)

Cobl

Heart

BPA

-28.0

2.289

0.004

NO

79

51

Cobl

Heart

VZ

-27.9

0.640

0.001

NO

79

51

Cobl

Lung

VZ

-19.7

2.033

0.005

NO

70

51

Cobl

Lung

BPA

-19.4

2.729

0.018

NO

70

51

Phlda2

Lung

VZ

-11.8

3.974

0.032

NO

79

68

Cobl

Heart

DEHP

-11.1

1.206

0.003

NO

79

68

Rtl1/Rtl1as

Lung

BPA

-10.0

1.649

0.021

YES (MAT)

90

80

Tnfrsf22

Heart

VZ

-9.9

1.942

0.026

NO

58

48

Rtl1/Rtl1as

Lung

VZ

-8.7

4.378

0.007

YES (MAT)

90

81

Tnfrsf22

Heart

BPA

-8.1

1.070

0.022

NO

58

50

Tnfrsf22

Lung

BPA

-7.6

1.305

0.023

NO

57

49

Ascl2

Heart

DEHP

-6.2

2.372

0.011

NO

54

48

Tnfrsf22

Lung

VZ

-5.5

2.043

0.025

NO

57

51

Atp10a

Heart

VZ

5.1

1.285

0.010

NO

48

53

Sfmbt2

Lung

VZ

6.5

0.690

0.003

NO

41

48

Zim1

Lung

BPA

6.7

1.473

0.010

YES (MAT)

90

97

Snrpn

Lung

VZ

9.9

2.488

0.019

YES (PAT)

11

21

Slc22a3

Lung

BPA

10.0

7.898

0.017

NO

50

60

Nespas (a)

Lung

VZ

10.3

2.375

0.036

YES (PAT)

3

13

Ascl2

Lung

BPA

12.7

3.520

0.000

NO

46

59

Asb4

Heart

VZ

27.2

8.101

0.019

NO

61

88

Asb4

Heart

BPA

27.2

2.591

0.015

NO

61

88

  1. Note: (a) and (b) denote different SNPs for the given DMR or transcript.
  2. Allele-specific DNA methylation or transcription was compared in 13.5 dpc embryos between ED- and vehicle-treated samples for each of the DMRs or imprinted transcripts, respectively. Changes in the average (n = 3) allele-specific features that were greater than 5% and were statistically significant (P <0.05) were tabulated and ordered according to the change in the maternal allele. Changes greater than 10% were rare. Baseline allele specificity of transcription or DNA methylation was observed (YES) or was not observed (NO) in the maternal (MAT) or paternal (PAT) allele in the vehicle-treated sample (cutoff 80%). Of those with baseline allele specificity, the expression or DNA methylation became less biased (relaxed) in a few instances (see the last column).